Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-23T20:35:21.276Z Has data issue: false hasContentIssue false
  • English
  • Français

ADIPOKINES AND PATHOPHYSIOLOGY OF PREGNANCY COMPLICATIONS – THE ROLE OF LEPTIN AND ADIPONECTIN

Published online by Cambridge University Press:  10 March 2014

SHALI MAZAKI-TOVI ,
EDI VAISBUCH  and
ROBERTO ROMERO
SHALI MAZAKI-TOVI
Affiliation:
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Tel Aviv, Israel.
EDI VAISBUCH
Affiliation:
Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel.
ROBERTO ROMERO*
Affiliation:
Perinatology Research Branch, NICHD/NIH/DHHS, Hutzel Women's Hospital, Detroit, MI.
*
Roberto Romero, MD, D(Med)Sci, Perinatology Research Branch, NICHD/NIH/DHHS, Hutzel Women's Hospital, Box No. 4, 3990 John R, Detroit, MI 48201. Email: romeror@mail.nih.gov
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Review Article
Information
Fetal and Maternal Medicine Review , Volume 24 , Issue 4 , November 2013 , pp. 232 - 259
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Spiegelman, BM, Flier, JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531–43.Google Scholar
2.Hotamisligil, GS, Shargill, NS, Spiegelman, BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.Google Scholar
3.Purohit, A, Ghilchik, MW, Duncan, L, Wang, DY, Singh, A, Walker, MM, et al.Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995; 80: 3052–8.Google ScholarPubMed
4.Mazurek, T, Zhang, L, Zalewski, A, Mannion, JD, Diehl, JT, Arafat, H, et al.Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–6.CrossRefGoogle ScholarPubMed
5.Alessi, MC, Peiretti, F, Morange, P, Henry, M, Nalbone, G, Juhan-Vague, I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860–7.Google Scholar
6.Karlsson, C, Lindell, K, Ottosson, M, Sjostrom, L, Carlsson, B, Carlsson, LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998; 83: 3925–9.Google Scholar
7.Fain, JN, Madan, AK, Hiler, ML, Cheema, P, Bahouth, SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273–82.CrossRefGoogle ScholarPubMed
8.Zhang, Y, Proenca, R, Maffei, M, Barone, M, Leopold, L, Friedman, JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–32.Google Scholar
9.Scherer, PE, Williams, S, Fogliano, M, Baldini, G, Lodish, HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–9.Google Scholar
10.Holcomb, IN, Kabakoff, RC, Chan, B, Baker, TW, Gurney, A, Henzel, W, et al.FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19: 4046–55.Google Scholar
11.Haider, DG, Schaller, G, Kapiotis, S, Maier, C, Luger, A, Wolzt, M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909–14.CrossRefGoogle ScholarPubMed
12.Yang, Q, Graham, TE, Mody, N, Preitner, F, Peroni, OD, Zabolotny, JM, et al.Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356–62.CrossRefGoogle ScholarPubMed
13.Steppan, CM, Lazar, MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18–23.Google Scholar
14.Ahima, RS, Flier, JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327–32.Google Scholar
15.Matsuzawa, Y, Funahashi, T, Kihara, S, Shimomura, I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29–33.Google Scholar
16.Barbier, M, Vidal, H, Desreumaux, P, Dubuquoy, L, Bourreille, A, Colombel, JF, et al.Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003; 27: 987–91.Google Scholar
17.Schaffler, A, Ehling, A, Neumann, E, Herfarth, H, Tarner, I, Scholmerich, J, et al.Adipocytokines in synovial fluid. JAMA 2003; 290: 1709–10.Google Scholar
18.Kusanovic, JP, Romero, R, Mazaki-Tovi, S, Chaiworapongsa, T, Mittal, P, Gotsch, F, et al.Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med 2008; 21: 902–16.Google Scholar
19.Verma, S, Li, SH, Wang, CH, Fedak, PW, Li, RK, Weisel, RD, et al.Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736–40.Google Scholar
20.Jia, SH, Li, Y, Parodo, J, Kapus, A, Fan, L, Rotstein, OD, et al.Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318–27.CrossRefGoogle ScholarPubMed
21.Mazaki-Tovi, S, Romero, R, Kusanovic, JP, Erez, O, Gotsch, F, Mittal, P, et al.Visfatin/pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008; 36: 485–96.Google Scholar
22.Gainsford, T, Willson, TA, Metcalf, D, Handman, E, McFarlane, C, Ng, A, et al.Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A 1996; 93: 14564–8.Google Scholar
23.Lord, GM, Matarese, G, Howard, JK, Baker, RJ, Bloom, SR, Lechler, RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901.Google Scholar
24.Catalano, PM, Hoegh, M, Minium, J, Huston-Presley, L, Bernard, S, Kalhan, S, et al.Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677–85.CrossRefGoogle ScholarPubMed
25.Mazaki-Tovi, S, Kanety, H, Sivan, E. Adiponectin and human pregnancy. Curr Diab Rep 2005; 5: 278–81.Google Scholar
26.Kajantie, E, Hytinantti, T, Hovi, P, Andersson, S. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab 2004; 89: 4031–6.Google Scholar
27.Mazaki-Tovi, S, Kanety, H, Pariente, C, Hemi, R, Wiser, A, Schiff, E, et al.Maternal serum adiponectin levels during human pregnancy. J Perinatol 2007; 27: 77–81.Google Scholar
28.Cortelazzi, D, Corbetta, S, Ronzoni, S, Pelle, F, Marconi, A, Cozzi, V, et al.Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007; 66: 447–53.Google Scholar
29.Mazaki-Tovi, S, Romero, R, Kusanovic, JP, Erez, O, Vaisbuch, E, Gotsch, F, et al.Adiponectin multimers in maternal plasma. J Matern Fetal Neonatal Med 2008; 21: 796–815.Google Scholar
30.Nien, JK, Mazaki-Tovi, S, Romero, R, Erez, O, Kusanovic, JP, Gotsch, F, et al.Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinat Med 2007; 35: 522–31.Google Scholar
31.Mazaki-Tovi, S, Romero, R, Kusanovic, JP, Vaisbuch, E, Erez, O, Than, NG, et al.Maternal visfatin concentration in normal pregnancy. J Perinat Med 2009; 37: 206–17.Google Scholar
32.Haugen, F, Drevon, CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007; 148: 5478–86.CrossRefGoogle ScholarPubMed
33.Mazaki-Tovi, S, Kanety, H, Pariente, C, Hemi, R, Yissachar, E, Schiff, E, et al.Insulin sensitivity in late gestation and early postpartum period: the role of circulating maternal adipokines. Gynecol Endocrinol 2011; 27: 725–31.Google Scholar
34.Nien, JK, Mazaki-Tovi, S, Romero, R, Kusanovic, JP, Erez, O, Gotsch, F, et al.Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 2007; 35: 513–21.Google Scholar
35.D’Anna, R, Baviera, G, Corrado, F, Giordano, D, Di Benedetto, A, Jasonni, VM. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol 2005; 106: 340–4.Google Scholar
36.D’Anna, R, Baviera, G, Corrado, F, Giordano, D, De, VA, Nicocia, G, et al.Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113: 1264–9.Google Scholar
37.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Kusanovic, JP, Erez, O, Gotsch, F, et al.Maternal serum adiponectin multimers in preeclampsia. J Perinat Med 2009; 37: 349–63.Google Scholar
38.Haugen, F, Ranheim, T, Harsem, NK, Lips, E, Staff, AC, Drevon, CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 2006; 290: E326–33.Google Scholar
39.Kajantie, E, Kaaja, R, Ylikorkala, O, Andersson, S, Laivuori, H. Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig 2005; 12: 433–9.Google Scholar
40.Lu, D, Yang, X, Wu, Y, Wang, H, Huang, H, Dong, M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet 2006; 95 (2): 121–6.Google Scholar
41.Mazaki-Tovi, S, Romero, R, Kim, SK, Vaisbuch, E, Kusanovic, JP, Erez, O, et al.Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med 2010; 23: 857–68.Google Scholar
42.Naruse, K, Yamasaki, M, Umekage, H, Sado, T, Sakamoto, Y, Morikawa, H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 2005; 65: 65–75.Google Scholar
43.Nien, JK, Mazaki-Tovi, S, Romero, R, Erez, O, Kusanovic, JP, Gotsch, F, et al.Adiponectin in severe preeclampsia. J Perinat Med 2007; 35: 503–12.Google Scholar
44.Ramsay, JE, Jamieson, N, Greer, IA, Sattar, N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 2003; 42: 891–4.Google Scholar
45.Vaisbuch, E, Romero, R, Mazaki-Tovi, S, Erez, O, Kim, SK, Chaiworapongsa, T, et al.Retinol binding protein 4 – a novel association with early-onset preeclampsia. J Perinat Med 2010; 38: 129–39.Google Scholar
46.Chen, D, Dong, M, Fang, Q, He, J, Wang, Z, Yang, X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci (Colch) 2005; 108: 81–4.Google Scholar
47.Fasshauer, M, Waldeyer, T, Seeger, J, Schrey, S, Ebert, T, Kratzsch, J, et al.Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol 2008; 158: 197–201.Google Scholar
48.Fasshauer, M, Waldeyer, T, Seeger, J, Schrey, S, Ebert, T, Kratzsch, J, et al.Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) 2008; 69: 69–73.Google Scholar
49.Seol, HJ, Kim, JW, Kim, HJ. Retinol-binding protein-4 is decreased in patients with preeclampsia in comparison with normal pregnant women. J Perinat Med 2011; 39: 287–9.Google Scholar
50.Stepan, H, Philipp, A, Roth, I, Kralisch, S, Jank, A, Schaarschmidt, W, et al.Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept 2011; 168: 69–72.Google Scholar
51.Suwaki, N, Masuyama, H, Nakatsukasa, H, Masumoto, A, Sumida, Y, Takamoto, N, et al.Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol 2006; 195: 1687–92.Google Scholar
52.Hendler, I, Blackwell, SC, Mehta, SH, Whitty, JE, Russell, E, Sorokin, Y, et al.The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 2005; 193: 979–83.Google Scholar
53.Briana, DD, Malamitsi-Puchner, A. Adipocytokines in normal and complicated pregnancies. Reprod Sci 2009; 16: 921–37.Google Scholar
54.Fasshauer, M, Bluher, M, Stumvoll, M, Tonessen, P, Faber, R, Stepan, H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007; 66: 434–9.Google Scholar
55.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Erez, O, Mittal, P, Chaiwaropongsa, T, et al.Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 2009; 37: 637–50.Google Scholar
56.Ranheim, T, Haugen, F, Staff, AC, Braekke, K, Harsem, NK, Drevon, CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004; 83: 341–7.Google Scholar
57.Worda, C, Leipold, H, Gruber, C, Kautzky-Willer, A, Knofler, M, Bancher-Todesca, D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191: 2120–4.Google Scholar
58.Chan, TF, Chen, YL, Lee, CH, Chou, FH, Wu, LC, Jong, SB, et al.Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006; 13: 364–7.Google Scholar
59.Mazaki-Tovi, S, Romero, R, Kusanovic, JP, Vaisbuch, E, Erez, O, Than, NG, et al.Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med 2009; 37: 218–31.Google Scholar
60.Haider, DG, Handisurya, A, Storka, A, Vojtassakova, E, Luger, A, Pacini, G, et al.Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007; 30: 1889–91.Google Scholar
61.Krzyzanowska, K, Krugluger, W, Mittermayer, F, Rahman, R, Haider, D, Shnawa, N, et al.Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Colch) 2006; 110: 605–9.Google Scholar
62.Kuzmicki, M, Telejko, B, Szamatowicz, J, Zonenberg, A, Nikolajuk, A, Kretowski, A, et al.High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009; 25: 258–63.Google Scholar
63.Lewandowski, KC, Stojanovic, N, Press, M, Tuck, SM, Szosland, K, Bienkiewicz, M, et al.Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50: 1033–7.CrossRefGoogle ScholarPubMed
64.Lewandowski, KC, Stojanovic, N, Bienkiewicz, M, Tan, BK, Prelevic, GM, Press, M, et al.Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008; 24: 300–5.Google Scholar
65.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Erez, O, Mittal, P, Chaiwaropongsa, T, et al.Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonatal Med 2009; 22: 887–904.Google Scholar
66.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Erez, O, Chaiwaropongsa, T, Mittal, P, et al.Maternal plasma visfatin in preterm labor. J Matern Fetal Neonatal Med 2009; 22: 693–704.Google Scholar
67.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Kim, SK, Kusanovic, JP, Chaiworapongsa, T, et al.Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term. J Perinat Med 2010; 38: 281–8.Google Scholar
68.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Kusanovic, JP, Chaiworapongsa, T, Kim, SK, et al.Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med. 2010; 38: 147–55.Google Scholar
69.Wiznitzer, A, Furman, B, Zuili, I, Shany, S, Reece, EA, Mazor, M. Cord leptin level and fetal macrosomia. Obstet Gynecol 2000; 96: 707–13.Google Scholar
70.Briana, DD, Boutsikou, M, Baka, S, Gourgiotis, D, Marmarinos, A, Hassiakos, D, et al.Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008; 93: 153–7.Google Scholar
71.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Erez, O, Mittal, P, Chaiwaropongsa, T, et al.Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn. J Perinat Med 2009; 37: 623–35.Google Scholar
72.Catov, JM, Patrick, TE, Powers, RW, Ness, RB, Harger, G, Roberts, JM. Maternal leptin across pregnancy in women with small-for-gestational-age infants. Am J Obstet Gynecol 2007; 196: 558.CrossRefGoogle ScholarPubMed
73.Mazaki-Tovi, S, Vaisbuch, E, Romero, R, Kusanovic, JP, Chaiworapongsa, T, Kim, SK, et al.Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate. J Matern Fetal Neonatal Med 2010; 23: 1119–28.Google Scholar
74.Briana, DD, Malamitsi-Puchner, A. The role of adipocytokines in fetal growth. Ann N Y Acad Sci 2010; 1205: 82–7.Google Scholar
75.Mazaki-Tovi, S, Kasher-Meron, M, Hemi, R, Haas, J, Gat, I, Lantsberg, D, et al.Chemerin is present in human cord blood and is positively correlated with birthweight. Am J Obstet Gynecol 2012; 207: 412e1–10.Google Scholar
76.Mazaki-Tovi, S, Kanety, H, Pariente, C, Hemi, R, Kuint, J, Yinon, Y, et al.Cord blood adiponectin and infant growth at one year. J Pediatr Endocrinol Metab 2011; 24: 411–8.Google Scholar
77.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Chaiworapongsa, T, Erez, O, Mittal, P, et al.Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection. J Perinat Med 2009; 38: 9–17.Google Scholar
78.Mazaki-Tovi, S, Vaisbuch, E, Romero, R, Kusanovic, JP, Chaiworapongsa, T, Kim, SK, et al.Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis. Am J Reprod Immunol 2010; 63: 252–62.Google Scholar
79.Vaisbuch, E, Romero, R, Mazaki-Tovi, S, Kusanovic, JP, Chaiworapongsa, T, Dong, Z, et al.Maternal plasma retinol binding protein 4 in acute pyelonephritis during pregnancy. J Perinat Med 2010; 38: 359–66.CrossRefGoogle ScholarPubMed
80.Mazaki-Tovi, S, Romero, R, Vaisbuch, E, Kusanovic, JP, Erez, O, Mittal, P, et al.Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with subclinical intrauterine infection/inflammation. J Matern Fetal Neonatal Med 2009; 23: 120–30.Google Scholar
81.Vaisbuch, E, Mazaki-Tovi, S, Kusanovic, JP, Erez, O, Than, GN, Kim, SK, et al.Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009; 23:111–9.Google Scholar
82.Mazaki-Tovi, S, Vaisbuch, E, Romero, R, Kusanovic, JP, Chaiworapongsa, T, Kim, SK, et al.Hyperresistinemia – a novel feature in systemic infection during human pregnancy. Am J Reprod Immunol 2010; 63: 358–69.CrossRefGoogle ScholarPubMed
83.Kelesidis, T, Kelesidis, I, Chou, S, Mantzoros, CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010; 152: 93–100.Google Scholar
84.Villanueva, EC, Myers, MG Jr. Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes 2008; 32 (Suppl 7): S8–12.Google Scholar
85.Masuzaki, H, Ogawa, Y, Sagawa, N, Hosoda, K, Matsumoto, T, Mise, H, et al.Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997; 3: 1029–33.Google Scholar
86.Sivan, E, Whittaker, PG, Sinha, D, Homko, CJ, Lin, M, Reece, EA, et al.Leptin in human pregnancy: the relationship with gestational hormones. Am J Obstet Gynecol 1998; 179: 1128–32.Google Scholar
87.Sivan, E, Mazaki-Tovi, S, Pariente, C, Efraty, Y, Schiff, E, Hemi, R, et al.Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003; 88: 5656–60.Google Scholar
88.Hu, E, Liang, P, Spiegelman, BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697–703.Google Scholar
89.Maeda, K, Okubo, K, Shimomura, I, Funahashi, T, Matsuzawa, Y, Matsubara, K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286–9.Google Scholar
90.Nakano, Y, Tobe, T, Choi-Miura, NH, Mazda, T, Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120: 803–12.Google Scholar
91.Arita, Y, Kihara, S, Ouchi, N, Takahashi, M, Maeda, K, Miyagawa, J, et al.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83.Google Scholar
92.Yang, WS, Lee, WJ, Funahashi, T, Tanaka, S, Matsuzawa, Y, Chao, CL, et al.Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–9.Google Scholar
93.Hotta, K, Funahashi, T, Arita, Y, Takahashi, M, Matsuda, M, Okamoto, Y, et al.Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–9.Google Scholar
94.Ouchi, N, Kihara, S, Arita, Y, Maeda, K, Kuriyama, H, Okamoto, Y, et al.Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–6.Google Scholar
95.Ouchi, N, Ohishi, M, Kihara, S, Funahashi, T, Nakamura, T, Nagaretani, H, et al.Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231–4.Google Scholar
96.Matsubara, M, Maruoka, S, Katayose, S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764–9.Google Scholar
97.Shibata, R, Ouchi, N, Kihara, S, Sato, K, Funahashi, T, Walsh, K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004; 279: 28670–4.Google Scholar
98.Pajvani, UB, Du, X, Combs, TP, Berg, AH, Rajala, MW, Schulthess, T, et al.Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073–85.Google Scholar
99.Waki, H, Yamauchi, T, Kamon, J, Ito, Y, Uchida, S, Kita, S, et al.Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352–63.Google Scholar
100.Tsao, TS, Tomas, E, Murrey, HE, Hug, C, Lee, DH, Ruderman, NB, et al.Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 50810–17.Google Scholar
101.Yamauchi, T, Kamon, J, Ito, Y, Tsuchida, A, Yokomizo, T, Kita, S, et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762–9.Google Scholar
102.Pajvani, UB, Hawkins, M, Combs, TP, Rajala, MW, Doebber, T, Berger, JP, et al.Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152–62.Google Scholar
103.Araki, S, Dobashi, K, Kubo, K, Asayama, K, Shirahata, A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab 2006; 91: 5113–16.Google Scholar
104.Aso, Y, Yamamoto, R, Wakabayashi, S, Uchida, T, Takayanagi, K, Takebayashi, K, et al.Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006; 55: 1954–60.CrossRefGoogle ScholarPubMed
105.Bluher, M, Brennan, AM, Kelesidis, T, Kratzsch, J, Fasshauer, M, Kralisch, S, et al.Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 2007; 30: 280–5.Google Scholar
106.Hara, K, Horikoshi, M, Yamauchi, T, Yago, H, Miyazaki, O, Ebinuma, H, et al.Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006; 29: 1357–62.Google Scholar
107.Modan-Moses, D, Stein, D, Pariente, C, Yaroslavsky, A, Ram, A, Faigin, M, et al.Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92: 1843–7.CrossRefGoogle ScholarPubMed
108.Wong, GW, Wang, J, Hug, C, Tsao, TS, Lodish, HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A 2004; 101: 10302–7.Google Scholar
109.Wang, Y, Lam, KS, Chan, L, Chan, KW, Lam, JB, Lam, MC, et al.Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 2006; 281: 16391–400.Google Scholar
110.Tsao, TS, Murrey, HE, Hug, C, Lee, DH, Lodish, HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002; 277: 29359–62.Google Scholar
111.Abke, S, Neumeier, M, Weigert, J, Wehrwein, G, Eggenhofer, E, Schaffler, A, et al.Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol 2006; 5: 17.Google Scholar
112.Neumeier, M, Weigert, J, Schaffler, A, Wehrwein, G, Muller-Ladner, U, Scholmerich, J, et al.Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 2006; 79: 803–8.Google Scholar
113.Schober, F, Neumeier, M, Weigert, J, Wurm, S, Wanninger, J, Schaffler, A, et al.Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007; 361: 968–73.Google Scholar
114.Kobayashi, H, Ouchi, N, Kihara, S, Walsh, K, Kumada, M, Abe, Y, et al.Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: e27–31.Google Scholar
115.Hara, K, Boutin, P, Mori, Y, Tobe, K, Dina, C, Yasuda, K, et al.Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536–40.Google Scholar
116.Tonelli, J, Li, W, Kishore, P, Pajvani, UB, Kwon, E, Weaver, C, et al.Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004; 53: 1621–9.Google Scholar
117.Salani, B, Briatore, L, Andraghetti, G, Adami, GF, Maggi, D, Cordera, R. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (Silver Spring) 2006; 14: 1511–4.CrossRefGoogle ScholarPubMed
118.Butte, NF, Hopkinson, JM, Nicolson, MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997; 82: 585–9.CrossRefGoogle ScholarPubMed
119.Schubring, C, Kiess, W, Englaro, P, Rascher, W, Dotsch, J, Hanitsch, S, et al.Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997; 82: 1480–3.Google Scholar
120.Hardie, L, Trayhurn, P, Abramovich, D, Fowler, P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997; 47: 101–6.Google Scholar
121.Highman, TJ, Friedman, JE, Huston, LP, Wong, WW, Catalano, PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998; 178: 1010–5.Google Scholar
122.Nuamah, MA, Sagawa, N, Yura, S, Mise, H, Itoh, H, Ogawa, Y, et al.Free-to-total leptin ratio in maternal plasma is constant throughout human pregnancy. Endocr J 2003; 50: 421–8.Google Scholar
123.Hauguel-De, MS, Lepercq, J, Catalano, P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006; 194: 1537–45.Google Scholar
124.Islami, D, Bischof, P, Chardonnens, D. Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur J Obstet Gynecol Reprod Biol 2003; 110: 169–75.Google Scholar
125.Lappas, M, Permezel, M, Rice, GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005; 146: 3334–42.Google Scholar
126.Mazaki-Tovi, S, Kanety, H, Pariente, C, Hemi, R, Schiff, E, Sivan, E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol 2005; 193: 1238–42.Google Scholar
127.Fuglsang, J, Skjaerbaek, C, Frystyk, J, Flyvbjerg, A, Ovesen, P. A longitudinal study of serum adiponectin during normal pregnancy. BJOG 2006; 113: 110–3.Google Scholar
128.Lopez-Bermejo, A, Fernandez-Real, JM, Garrido, E, Rovira, R, Brichs, R, Genaro, P, et al.Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clin Endocrinol (Oxf) 2004; 61: 544–52.Google Scholar
129.Williams, MA, Havel, PJ, Schwartz, MW, Leisenring, WM, King, IB, Zingheim, RW, et al.Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women. Paediatr Perinat Epidemiol 1999; 13: 190–204.Google Scholar
130.Anim-Nyame, N, Sooranna, SR, Steer, PJ, Johnson, MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000; 15: 2033–6.Google Scholar
131.Chappell, LC, Seed, PT, Briley, A, Kelly, FJ, Hunt, BJ, Charnock-Jones, DS, et al.A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127–36.Google Scholar
132.Henson, MC, Castracane, VD. Leptin in pregnancy: an update. Biol Reprod 2006; 74: 218–29.Google Scholar
133.McCarthy, JF, Misra, DN, Roberts, JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999; 180: 731–6.Google Scholar
134.Poston, L. Leptin and preeclampsia. Semin Reprod Med 2002; 20: 131–8.CrossRefGoogle ScholarPubMed
135.Laivuori, H, Kaaja, R, Koistinen, H, Karonen, SL, Andersson, S, Koivisto, V, et al.Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 2000; 49: 259–63.Google Scholar
136.Kautzky-Willer, A, Pacini, G, Tura, A, Bieglmayer, C, Schneider, B, Ludvik, B, et al.Increased plasma leptin in gestational diabetes. Diabetologia 2001; 44: 164–72.Google Scholar
137.Kirwan, JP, Hauguel-De, MS, Lepercq, J, Challier, JC, Huston-Presley, L, Friedman, JE, et al.TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207–13.Google Scholar
138.Okereke, NC, Huston-Presley, L, Amini, SB, Kalhan, S, Catalano, PM. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004; 287: E472–9.Google Scholar
139.Suwaki, N, Masuyama, H, Nakatsukasa, H, Masumoto, A, Sumida, Y, Takamoto, N, et al.Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol 2006; 195: 1687–92.Google Scholar
140.Takemura, Y, Osuga, Y, Koga, K, Tajima, T, Hirota, Y, Hirata, T, et al.Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia. J Reprod Immunol 2007; 73: 60–5.CrossRefGoogle ScholarPubMed
141.Nakatsukasa, H, Masuyama, H, Takamoto, N, Hiramatsu, Y. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J 2008; 55: 565–73.Google Scholar
142.Masuyama, H, Segawa, T, Sumida, Y, Masumoto, A, Inoue, S, Akahori, Y, et al.Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 2010; 117: 314–20.Google Scholar
143.Liu, Y, Zhu, L, Pan, Y, Sun, L, Chen, D, Li, X. Adiponectin levels in circulation and breast milk and mRNA expression in adipose tissue of preeclampsia women. Hypertens Pregnancy 2012; 31: 40–9.CrossRefGoogle ScholarPubMed
144.Nanda, S, Yu, CK, Giurcaneanu, L, Akolekar, R, Nicolaides, KH. Maternal serum adiponectin at 11–13 weeks of gestation in preeclampsia. Fetal Diagn Ther 2011; 29: 208–15.Google Scholar
145.Masuyama, H, Nobumoto, E, Inoue, S, Hiramatsu, Y. Potential interaction of brain natriuretic peptide with hyperadiponectinemia in preeclampsia. Am J Physiol Endocrinol Metab 2012; 302: E687–93.Google Scholar
146.Masuyama, H, Nakatsukasa, H, Takamoto, N, Hiramatsu, Y. Correlation between soluble endoglin, vascular endothelial growth factor receptor -1 and adipocytokines in preeclampsia. J Clin Endocrinol Metab 2007; 92 (7): 2672–9.Google Scholar
147.Ichida, K, Moriyama, T, Morita, H, Kondo, T, Yoshida, S, Ohara, N, et al.Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women. Gynecol Endocrinol 2007; 23: 238–43.Google Scholar
148.Ouyang, Y, Chen, H, Chen, H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 110–4.Google Scholar
149.Herse, F, Bai, Y, Staff, AC, Yong-Meid, J, Dechend, R, Zhou, R. Circulating and uteroplacental adipocytokine concentrations in preeclampsia. Reprod Sci 2009; 16: 584–90.Google Scholar
150.Mori, T, Shinohara, K, Wakatsuki, A, Watanabe, K, Fujimaki, A. Adipocytokines and endothelial function in preeclamptic women. Hypertens Res 2010; 33: 250–4.Google Scholar
151.O’Sullivan, AJ, Kriketos, AD, Martin, A, Brown, MA. Serum adiponectin levels in normal and hypertensive pregnancy. Hypertens Pregnancy 2006; 25: 193–203.Google Scholar
152.Savvidou, MD, Sotiriadis, A, Kaihura, C, Nicolaides, KH, Sattar, N. Circulating levels of adiponectin and leptin at 23–25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci (Colch) 2008; 115: 219–24.CrossRefGoogle ScholarPubMed
153.Dalamaga, M, Srinivas, SK, Elovitz, MA, Chamberland, J, Mantzoros, CS. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study. Metabolism 2011; 60: 1539–44.Google Scholar
154.Valdes, ER, Lattes, KA, Munoz, HS, Barja, PY, Papapietro, KV. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction. Gynecol Obstet Invest 2011; 72: 152–6.Google Scholar
155.Saarela, T, Hiltunen, M, Helisalmi, S, Heinonen, S, Laakso, M. Adiponectin gene haplotype is associated with preeclampsia. Genet Test 2006; 10: 35–9.CrossRefGoogle ScholarPubMed
156.Ategbo, JM, Grissa, O, Yessoufou, A, Hichami, A, Dramane, KL, Moutairou, K, et al.Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91: 4137–43.Google Scholar
157.Kinalski, M, Telejko, B, Kuzmicki, M, Kretowski, A, Kinalska, I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005; 37: 450–4.Google Scholar
158.Thyfault, JP, Hedberg, EM, Anchan, RM, Thorne, OP, Isler, CM, Newton, ER, et al.Gestational diabetes is associated with depressed adiponectin levels. J Soc Gynecol Investig 2005; 12: 41–5.Google Scholar
159.Retnakaran, R, Hanley, AJ, Raif, N, Connelly, PW, Sermer, M, Zinman, B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799–800.CrossRefGoogle ScholarPubMed
160.Retnakaran, R, Hanley, AJ, Raif, N, Hirning, CR, Connelly, PW, Sermer, M, et al.Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48: 993–1001.Google Scholar
161.Tsai, PJ, Yu, CH, Hsu, SP, Lee, YH, Huang, IT, Ho, SC, et al.Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005; 21: 1095–9.Google Scholar
162.Filippi, E, Sentinelli, F, Trischitta, V, Romeo, S, Arca, M, Leonetti, F, et al.Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2004; 12: 199–205.Google Scholar
163.Gonzalez-Sanchez, JL, Zabena, CA, Martinez-Larrad, MT, Fernandez-Perez, C, Perez-Barba, M, Laakso, M, et al.An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 2005; 13: 807–12.Google Scholar
164.Hu, FB, Doria, A, Li, T, Meigs, JB, Liu, S, Memisoglu, A, et al.Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004; 53: 209–13.Google Scholar
165.Lee, YY, Lee, NS, Cho, YM, Moon, MK, Jung, HS, Park, YJ, et al.Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med 2005; 22: 569–75.Google Scholar
166.Menzaghi, C, Ercolino, T, Di, PR, Berg, AH, Warram, JH, Scherer, PE, et al.A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306–12.Google Scholar
167.Nakatani, K, Noma, K, Nishioka, J, Kasai, Y, Morioka, K, Katsuki, A, et al.Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. Int J Mol Med 2005; 15: 173–7.Google Scholar
168.Stumvoll, M, Tschritter, O, Fritsche, A, Staiger, H, Renn, W, Weisser, M, et al.Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51: 37–41.Google Scholar
169.Kim, MJ, Yoo, KH, Park, HS, Chung, SM, Jin, CJ, Lee, Y, et al.Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J 2005; 46: 42–50.Google Scholar
170.Putz, DM, Goldner, WS, Bar, RS, Haynes, WG, Sivitz, WI. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism 2004; 53: 1454–61.Google Scholar
171.Weyer, C, Funahashi, T, Tanaka, S, Hotta, K, Matsuzawa, Y, Pratley, RE, et al.Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–5.Google Scholar
172.Williams, MA, Qiu, C, Muy-Rivera, M, Vadachkoria, S, Song, T, Luthy, DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306–11.Google Scholar
173.Sattar, N, Greer, IA, Pirwani, I, Gibson, J, Wallace, AM. Leptin levels in pregnancy: marker for fat accumulation and mobilization? Acta Obstet Gynecol Scand 1998; 77: 278–83.Google Scholar
174.Mise, H, Sagawa, N, Matsumoto, T, Yura, S, Nanno, H, Itoh, H, et al.Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 1998; 83: 3225–9.Google Scholar
175.Laivuori, H, Kaaja, R, Koistinen, H, Karonen, SL, Andersson, S, Koivisto, V, et al.Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 2000; 49: 259–63.CrossRefGoogle ScholarPubMed
176.Teppa, RJ, Ness, RB, Crombleholme, WR, Roberts, JM. Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism 2000; 49: 1043–8.Google Scholar
177.Martinez-Abundis, E, Gonzalez-Ortiz, M, Pascoe-Gonzalez, S. Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet 2000; 264: 71–3.CrossRefGoogle ScholarPubMed
178.Vitoratos, N, Chrystodoulacos, G, Kouskouni, E, Salamalekis, E, Creatsas, G. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol 2001; 96: 59–62.Google Scholar
179.Laml, T, Preyer, O, Hartmann, BW, Ruecklinger, E, Soeregi, G, Wagenbichler, P. Decreased maternal serum leptin in pregnancies complicated by preeclampsia. J Soc Gynecol Investig 2001; 8: 89–93.Google Scholar
180.Bartha, JL, Romero-Carmona, R, Escobar-Llompart, M, Comino-Delgado, R. The relationships between leptin and inflammatory cytokines in women with pre-eclampsia. BJOG 2001; 108: 1272–6.Google Scholar
181.Clausen, T, Djurovic, S, Reseland, JE, Berg, K, Drevon, CA, Henriksen, T. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 2002; 23: 380–5.Google Scholar
182.Gursoy, T, Aliefendioglu, D, Aslan, AT, Gunduz, M, Haberal, A, Senes, M, et al.Preeclampsia disrupts the normal physiology of leptin. Am J Perinatol 2002; 19: 303–10.Google Scholar
183.Kafulafula, GE, Moodley, J, Ojwang, PJ, Kagoro, H. Leptin and pre-eclampsia in black African parturients. BJOG 2002; 109: 1256–61.Google Scholar
184.Chan, TF, Su, JH, Chung, YF, Hsu, YH, Yeh, YT, Jong, SB, et al.Amniotic fluid and maternal serum leptin levels in pregnant women who subsequently develop preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 108: 50–3.Google Scholar
185.Salomon, LJ, Benattar, C, Audibert, F, Fernandez, H, Duyme, M, Taieb, J, et al.Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003; 189: 1517–22.Google Scholar
186.Atamer, Y, Erden, AC, Demir, B, Kocyigit, Y, Atamer, A. The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 2004; 83: 425–30.CrossRefGoogle ScholarPubMed
187.Celik, O, Hascalik, S, Ozerol, E, Hascalik, M, Yologlu, S. Cerebrospinal fluid leptin levels in preeclampsia: relation to maternal serum leptin levels. Acta Obstet Gynecol Scand 2004; 83: 519–23.Google Scholar
188.Ning, Y, Williams, MA, Muy-Rivera, M, Leisenring, WM, Luthy, DA. Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study. J Matern Fetal Neonatal Med 2004; 15: 186–92.Google Scholar
189.Kocyigit, Y, Bayhan, G, Atamer, A, Atamer, Y. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 2004; 18: 341–8.Google Scholar
190.Kocyigit, Y, Atamer, Y, Atamer, A, Tuzcu, A, Akkus, Z. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 2004; 19: 267–73.Google Scholar
191.Baksu, A, Ozkan, A, Goker, N, Baksu, B, Uluocak, A. Serum leptin levels in preeclamptic pregnant women: relationship to thyroid-stimulating hormone, body mass index, and proteinuria. Am J Perinatol 2005; 22: 161–4.Google Scholar
192.Adali, E, Yildizhan, R, Kolusari, A, Kurdoglu, M, Bugdayci, G, Sahin, HG, et al.Increased visfatin and leptin in pregnancies complicated by pre-eclampsia. J Matern Fetal Neonatal Med 2009; 22:873-9 1–7.Google Scholar
193.Samolis, S, Papastefanou, I, Panagopoulos, P, Galazios, G, Kouskoukis, A, Maroulis, G. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies–role of leptin as a marker of pre-eclampsia: a prospective case-control study. Gynecol Endocrinol 2010; 26: 338–43.Google Scholar
194.Molvarec, A, Szarka, A, Walentin, S, Beko, G, Karadi, I, Prohaszka, Z, et al.Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 2011; 9: 124.Google Scholar